The development of noninvasive methods to detect and monitor tumors continues to be a
major challenge in oncology. We used digital polymerase chain reaction–based technologies …

Earlier detection is key to reducing cancer deaths. Here, we describe a blood test that can
detect eight common cancer types through assessment of the levels of circulating proteins and …

The American Joint Committee on Cancer/Union Internationale Contre le Cancer ( AJCC /
UICC ) TNM staging system provides the most reliable guidelines for the routine …

Detection of circulating tumor DNA (ctDNA) after resection of stage II colon cancer may
identify patients at the highest risk of recurrence and help inform adjuvant treatment decisions. …

Studies of the distributions of species of seasonal woodland habitats in South America by
means of dot-mapping and phytosociological analyses indicate the presence of three nodal …

Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor …

Background In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE)
trial, now published in the Journal, we report that the daily use of aspirin did not provide a …

Background Programmed death 1 (PD-1) blockade has clinical benefit in microsatellite-instability–high
(MSI-H) or mismatch-repair–deficient (dMMR) tumors after previous therapy. The …

Background The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …

To assist in the greatly increasing number of applications of Raman microscopy as a tool for
non-intrusive, in situ archaeometric analysis, the Raman spectra of over 60 pigments, both …